| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |